
Koseceft SB 1000mg/500mg Injection
Marketer
Kosmed Formulations
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Koseceft SB 1000mg/500mg Injection
Cefixime and Sulbactam injection (1000mg/500mg) is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, hindering infection spread. Administration must be strictly under medical guidance. Complete the prescribed treatment regimen; premature cessation can compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration contribute to faster recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Primary Ingredients of Koseceft SB 1000mg/500mg Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Koseceft SB 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Koseceft SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Koseceft SB 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Koseceft SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Koseceft SB 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Koseceft SB 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Koseceft SB 1000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
Cefixime/Sulbactam injection (1000mg/500mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Koseceft SB 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Koseceft SB 1000mg/500mg Injection could lead to reduced awareness, impaired vision, drowsiness, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Koseceft SB 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Koseceft SB 1000mg/500mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Koseceft SB 1000mg/500mg Injection is unnecessary in individuals with mild to moderate liver dysfunction.
What if you forget to take Koseceft SB 1000mg/500mg Injection :
Omit a Koseceft SB 1000mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Koseceft SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
